Kenneth Cusi - Concepedia

Author

Kenneth Cusi

University of Florida ORCID

Also Known As

B.-W. Lee, Cusi, Kenneth, K CUSI, K Cusi, K. Cusi, KENNETH CUSI, Kenneth Cusi, Kenneth J. Cusi, Michael Clare-Salzler

378

Publications

53.3K

Citations

H-Index

120

Concepts

All Affiliations

University of Florida The University of Texas Health Science Center at San Antonio Malcom Randall VA Medical Center Murphy Oil Corporation (United States)University of California San Diego

About

Kenneth Cusi is an author at University of Florida specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	64	10.9K
2	Health Sciences	35	47	9.6K
3	Public Health	6	7	492
4	Business	2	2	145
5	Applied Physiology	2	2	238

Kenneth Cusi

162

Publications

32.9K

Citations

H-Index

Page 1

	Year	Citations
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Hepatology	2012	3.8K
A multisociety Delphi consensus statement on new fatty liver disease nomenclature Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Hepatology Evidence-based MedicinePathologyFatty Liver DiseaseObesityMetabolic Syndrome	2023	2.5K
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of<i>PGC1</i>and<i>NRF1</i> Mary‐Elizabeth Patti, Atul J. Butte, Sarah Crunkhorn, Proceedings of the National Academy of Sciences	2003	1.9K
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis Renata Belfort, Stephen A. Harrison, Kenneth Brown, New England Journal of Medicine	2006	1.8K
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology Naga Chalasani, Zobair M. Younossi, Joel E. Lavine, Gastroenterology ObesityMetabolic SyndromePractice GuidelineMetabolic Associated SteatohepatitisHepatology	2012	1.8K
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, New England Journal of Medicine	2020	1.7K
Insulin resistance differentially affects the PI 3-kinase– and MAP kinase–mediated signaling in human muscle Kenneth Cusi, Katsumi Maezono, Abdullah A. Osman, Journal of Clinical Investigation	2000	1.1K
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus Kenneth Cusi, Beverly Orsak, Fernando Bril, Annals of Internal Medicine	2016	957
Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda, The Journal of Clinical Endocrinology & Metabolism	2002	695
Relationship Between Hepatic/Visceral Fat and Hepatic Insulin Resistance in Nondiabetic and Type 2 Diabetic Subjects Amalia Gastaldelli, Kenneth Cusi, Maura Pettiti, Gastroenterology Insulin ResistanceMetabolic SyndromeHepatologyDiabetesPhysiology	2007	603

Page 1